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Membrane transporters are involved in enormous number of physiological and pathological processes.
Under oxidative stress they become targets for reactive oxygen species and its derivatives which cause
protein damage and/or inﬂuence protein function(s). The molecular mechanisms of this interaction are
poorly understood. Here we describe a novel lipid-mediated mechanism by which biologically important
reactive aldehydes (RAs; 4-hydroxy-2-nonenal, 4-hydroxy-2-hexenal and 4-oxo-2-nonenal) modify the
activity of several membrane transporters. We revealed that investigated RAs covalently modify the
membrane lipid phosphatidylethanolamine (PE), that lead to the formation of different membrane active
adducts. Molecular dynamic simulations suggested that anchoring of PE-RA adducts in the lipid head-
group region is primarily responsible for changes in the lipid membrane properties, such as membrane
order parameter, boundary potential and membrane curvature. These caused the alteration of transport
activity of mitochondrial uncoupling protein 1, potassium carrier valinomycin and ionophore CCCP. In
contrast, neither direct protein modiﬁcation by RAs as previously shown for cytosolic proteins, nor its
insertion into membrane bilayers inﬂuenced the studied transporters. Our results explain the diversity of
aldehyde action on cell proteins and open a new ﬁeld in the investigation of lipid-mediated effects of
biologically important RAs on membrane receptors, channels and transporters.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Mitochondria produce a substantial amount of superoxide an-
ion •−·O2 , which is able to give rise to other reactive species, amongInc. This is an open access article u
-nonenal; HNE, 4-hydroxy-2-
g protein 1; CCCP, carbonyl
cid; DHA, docosahexaenoic
species; FA, long chain fatty
lamine; DOPC, 1,2-dioleoyl-
sphatidylglycerol; DPPC, 1,2-
Pohl).them reactive aldehydes, such as 4-hydroxy-2-nonenal (HNE),
4-oxo-2-nonenal (ONE) and 4-hydroxy-2-hexenal (HHE) [1].
Whereas HNE and ONE are peroxidation products derived from
n-6 polyunsaturated fatty acids (PUFA), like arachidonic or linoleic
acid, HHE is a peroxidation product of n-3 PUFAs [2]. These alde-
hydes are much more stable than ROS; their non-charged struc-
ture enables them to move far from their place of origin to target
proteins, DNA and phospholipids [3–7]. HNE, the most intensively
studied aldehyde, was found in different tissues and blood plasma.
At low concentrations, HNE is involved in signaling processes, cell
proliferation, differentiation and apoptosis [8]. At high con-
centrations HNE is toxic and was reported to be involved in the
pathogenesis of many diseases [9]. The molecular mechanismsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stood. An emerging body of evidence shows that not only HNE, but
also other biologically active aldehydes mediate non-enzymatic
post-translational protein modiﬁcations by formation of adducts
with several amino acids such as cysteine, lysine, histidine and, in
case of ONE, arginine [6,10–12]. Few reports demonstrate the
ability of RA to form adducts with aminophospholipids, such as
phosphatidylethanolamine (PE) [13,14]. The consequences of RA-
PE adduct formation on the function of membrane proteins have
thus far been poorly studied.
Uncoupling proteins – membrane proteins that belong to the
superfamily of mitochondrial anion transporters – have been
controversially discussed as to whether they regulate ROS and as
negative feedback are regulated by ROS and their derivatives
[5,15,16]. In our previous work, we demonstrated that although
HNE did not inﬂuence the activity of the protein directly, it strongly
potentiated the UCP-mediated proton transport in the presence of
fatty acids [5]. We ﬁrst hypothesized that HNE binding to Cys, Lys
and His residues of protein induces a conformational change of
UCP1 that leads to the strong potentiation of its activity. However,
although UCP1, with its 7 cysteine, 17 lysine and 3 histidine re-
sidues represents a good target for aldehyde action, blocking the
afore-mentioned amino acids did not lead to complete inhibition of
the HNE-effects. This knowledge led us to the current hypothesis
that the molecular mechanism may rather entail covalent mod-
iﬁcation of the aminophospholipids, which then leads to the al-
teration of the lipid membrane parameters [17] and to the facil-
itation of fatty acids transport mediated by uncoupling proteins.
In this work, we therefore compared the effect of biologically
important reactive aldehydes (HNE, ONE and HHE) which have
similar structures, but are known for their different activity in vivo,
on UCP1, valinomycin and CCCP transport function. By comparing
the three aldehydes, we aimed to reveal (i) whether the RA-
mediated modulation of protein activity is mediated by a lipid
environment rather than by direct interaction between aldehyde
and protein, and (ii) whether deﬁnite structural differences lead to
different aldehyde reactivity.2. Materials and methods
2.1. Chemicals
Hexane, hexadecane, Na2SO4, MES, TRIS, EGTA, ammonium
formiate, 5-doxyl stearic acid, DOPC, DOPE, cardiolipin and ara-
chidonic acid were purchased from Sigma Aldrich GmbH (Ger-
many). ONE, HNE and HHE came from Cayman Chemicals. E. coli
polar lipid and DPhPC, were purchased from Avanti polar lipids.
ULC/MS grade methanol was supplied by Biosolve BV (Valk-
enswaard, Netherlands). Chloroform was from Merck KGaA
(Darmstadt, Germany).
2.2. Reconstitution of UCP1 in liposomes
The recombinant uncoupling protein (mUCP1) was puriﬁed
from E. coli inclusion bodies and reconstituted into liposomes as
previously described [18]. The free fatty acid (arachidonic acid
(AA), 20:4, n-6) at a concentration of 15 mol% was directly added
to the lipid phase before membrane formation. RAs were directly
added to the buffer solution.
2.3. Formation and measurements of planar membrane electrical
parameters
Planar lipid bilayers were formed from proteoliposomes or li-
posomes on the tip of plastic pipettes as previously described [18].Membrane formation and bilayer quality was monitored by ca-
pacitance measurements (0.7270.05 mF/cm2). The capacitance
neither depends on protein nor on fatty acid or reactive aldehydes
(RA) content. Current–voltage (I–V) characteristics were measured
by a patch-clamp ampliﬁer (EPC 10, HEKA Elektronik Dr. Schulze
GmbH, Germany). Total membrane conductance was calculated
from a linear ﬁt of experimental data (I) at applied voltages in the
range of 50 mV to 50 mV as previously described [17]. For this
study, liposomes and proteoliposomes were subsequently in-
cubated with different concentrations of each RA for 15 min at
32 °C.
2.4. Preparation of liposomes and measurement of Zeta-potential
For liposome formation, lipids (DOPC and DOPE) were mixed in
the required ratio, the solvent (chloroform) was removed by eva-
poration and an appropriate volume of buffer (50 mM Na2SO4,
10 mM TRIS, 10 mM MES, 0.6 mM EGTA) was added to reach the
ﬁnal lipid concentration of 0.2 mg/ml. Unilamellar vesicles were
obtained using a small-volume extruder (Avanti Polar lipids Inc.)
with a 100 nm ﬁlter. The liposomes were incubated with each RA
at a concentration of 0.5 mM for 15 min at RT. Measurements of
the electrophoretic mobility of liposomes in an electrical ﬁeld
were performed by a Malvern Zetasizer Nano ZS device (Malvern,
UK) at 25 °C and pH 7.32. The obtained velocity data were used for
the calculation of electrophoretic mobility of liposomes. The
Smoluchowski model was applied to calculate the Zeta-potential.
2.5. Determination of order parameters in lipid bilayers using the
Electron Paramagnetic Resonance (EPR) method
The order parameter of the lipid bilayer was determined by
inserting 5-doxyl stearic acid spin label (5-DSA) (7.5 nmol/mg li-
pid) into liposomes (5 mg lipid/ml) in the presence of 0.5 mM RAs
and/or respective solvents, if required. EPR measurements and
calculation of order parameters were performed as previously
described [5].
2.6. Analysis of fatty acid residues by gas spectrometry
Unilamellar liposomes (3 mg/ml) made from E. coli polar lipids
with or without AA, were incubated with HNE, ONE or HHE for
30 min. The phospholipid extraction and analysis of the fatty acid
tails was performed as described previously [19]. In brief, treat-
ment with 0.5 M KOH/MeOH at room temperature converted the
fatty acid residues of the phospholipids into their corresponding
fatty acid methyl esters (FAME). FAMEs were then extracted with
n-hexane and analyzed by GC. Fatty acids were identiﬁed by
comparison with standard references.
2.7. Mass spectrometric analysis of modiﬁed lipid vesicles
Aldehyde-treated lipid vesicles were mixed with chloroform:
methanol (1:1; v/v), an organic phase containing modiﬁed lipids
was separated by centrifugation (4000 g, 10 min, RT), diluted 1:5
(v/v) in ESI solution (methanol: chloroform (2:1; v/v) containing
5 mmol/L ammonium formate) and directly analyzed by direct
injection using robotic nanoﬂow ion source TriVersa NanoMate
(AdvionBio Sciences, Ithaca NY) equipped with nanoelectrospray
chips (1.5 kV ionization voltage, 0.4 psi back pressure) coupled to a
LTQ Orbitrap XL ETD mass spectrometer (Thermo Fischer Scientiﬁc
GmbH, Bremen, Germany). The temperature of the transfer capil-
lary was set to 200 °C and the tube lens voltage to 115 V. Mass
spectra were recorded from m/z 400 to 2000 in the Orbitrap mass
analyzer at a mass resolution of 100,000 at m/z 400. Tandem mass
spectra were acquired by performing CID (isolation width 1–1.5 u,
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vation Q 0.25) in the linear ion trap. Data were acquired and
analyzed using Xcalibur software (version 2.0.7, Thermo Fisher
Scientiﬁc, San Jose, CA, USA). All MS/MS spectra were manually
annotated.2.8. Molecular dynamics (MD) simulations
Molecular dynamics (MD) simulations of lipid bilayer mem-
branes were performed in aqueous solutions as closely as possible
to match experimental conditions. However, due to the lack of
available force ﬁeld parameters, the 1,2-Dioleoyl-sn-glycero-3-
phosphocholine (DOPC) bilayer used in the experiments was re-
placed by a 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)
bilayer while cardiolipin was not included in simulations. DPPC,
4-hydroxynonenal (HNE), 4-oxononenal (ONE), Michael-HNE ad-
duct, Schiff-HNE adduct and Schiff-ONE adduct were described
with SLipids [20–22] and CHARMM [22–24] force ﬁeld. All missing
bonding and nonbonding parameters of HNE, ONE and adduct
molecules in the existing Slipids force ﬁeld were updated with
compatible CHARMM36 parameters while atomic charges were
calculated by the Merz-Singh–Kollman scheme [25] which con-
sisted of B3LYP/6-31G(d) geometry optimization of the molecule of
interest and subsequent single point ESP charge calculation using
B3LYP/cc-pVTZ method.
Bilayers containing 128 lipid molecules were constructed by
placing individual lipids on an 88 grid resulting in a bilayer of
two monolayers, each containing 64 individual lipid molecules
(Table S2). In the case of mixed bilayers, HNE, ONE and adduct
molecules, respectively, were randomly placed in each of the
leaﬂets replacing the same number of DPPC molecules. Lipid bi-
layer membranes were equilibrated until a constant area per lipid
was obtained (i.e., at least 100 ns for DPPC bilayers and 200 ns for
all other bilayers). All systems were placed in a unit cell and
solvated by ca. 11,000 water molecules using the TIP3P water
model [24]. The size of the unit cell was approximately
6.56.512.0 nm3. The system was set up so that the lipid bi-
layer spanned the xy plane and the z coordinate was normal to the
bilayer. 3D periodic boundary conditions were employed with
long-range electrostatic interactions beyond the non-bonded cut-
off of 1 nm. This accounted for using the particle-mesh Ewald
procedure [26] with a Fourier spacing of 1.2 nm. The real space
Coulomb interactions were cut off at 1 nm, while van der Waals
interactions were cut-off at 1.4 nm. Simulations were performed
with semi-isotropic pressure coupling, independently, in the di-
rections parallel and perpendicular to the bilayer normal, em-
ploying the Parrinello–Rahman algorithm [27]. The pressure was
set to 1 bar and a coupling constant of 10 ps1 was employed. Two
temperatures were used for simulations – 310 K (which closely
matched an experimental temperature of 305 K) and 323 K (which
is sufﬁciently above phase transition temperature of DPPC lipid)
and independently controlled with the Nose–Hoover thermostat
[28] for the lipid water sub-systems, with a coupling constant of
0.5 ps1. Bond lengths within the simulated molecules were
constrained using the LINCS algorithm [29]. Water bond lengths
were kept constant employing the SETTLE method [30]. Equations
of motion were integrated using the leap-frog algorithm with a
time step of 2 fs. All the simulated systems were equilibrated for at
least 100 ns, depending on the system, with a subsequent 100 ns
simulation time used for analysis. MD simulations were performed
with the GROMACS program package, version 4.5.4 [31] while
quantum chemical calculations were performed using Gaussian 09
[32].2.9. Statistical analysis
Data are presented as mean values7SD. Statistical signiﬁcance
was determined using Student's t-test.3. Results
3.1. Effect of ONE, HNE and HHE on UCP1 reconstituted in bilayer
membranes of various lipid compositions
We have previously shown that 4-hydroxy-2-nonenal (HNE)
only activates inner membrane mitochondrial uncoupling proteins
1 and 2 (UCP1 and UCP2) in the presence of fatty acids [5]. To
reveal whether other biologically important reactive aldehydes
(RA) can directly inﬂuence protein activity and whether the che-
mical structure of aldehyde is important for the magnitude of the
effect, we have now investigated 4-hydroxy-2E-hexenal (C6H10O2,
HHE), which has a shorter backbone than HNE, and 4-oxo-2-
nonenal (C9H14O2, ONE), which has the same length, but has a
carbonyl instead of a hydroxyl group at C4 (Fig. 1a). For this pur-
pose, we reconstituted UCP1 in artiﬁcial bilayer membranes made
from E. coli polar lipids and compared relative conductances G/G0
of FA-free and FA-containing membranes in the presence (G) and
absence (G0) of different RAs. Conductance (G) was determined at
0 mV from current–voltage (I–V) characteristics, which were linear
in the range of –50 to 50 mV (Fig. S1). E. coli polar lipid extract
which contained phosphatidylethanolamine, phosphatidylglycerol
and cardiolipin (PE:PG:CL¼71.4:23.4:5.2, in mol%) respectively,
shows that both HHE and ONE, as similar to HNE, cannot directly
activate UCP1 (Fig. 1b, inset). Comparison of G/G0 for investigated
aldehydes shows a concentration-dependent increase of activation
potential in this order: HHE«HNEoONE over the whole con-
centration range (90–800 mM, Fig. 1b). The much lower hydro-
phobicity of HHE, which is three C-atoms shorter than HNE, could
be the most likely explanation for its smaller inﬂuence on mem-
brane conductance. Although aldehyde concentrations used in this
study are higher than those typically reported as non-toxic in cells,
the lack of a proton leak in the lipid membrane without PE en-
sured that RA concentrations used in our system were not toxic. It
is worth mentioning that local aldehyde concentrations (for ex-
ample in the vicinity of the membrane) can be higher than re-
ported for the whole cell or tissue.
To investigate whether the membrane lipid composition in-
ﬂuences the aldehyde activation potential in membranes recon-
stituted with FA and UCP1, we further compared membranes
containing DOPE:DOPC:CL and DOPC:CL as a model for an inner
mitochondrial membrane and as a “PE-knockout” model, respec-
tively. Fig. 1c shows that G0 does not depend on lipid composition
of the membrane that has only been reconstituted with protein
(white bars). The addition of HNE or ONE only signiﬁcantly in-
creased G in this order G(ONE)4G(HNE) in bilayers which con-
tained DOPE. In contrast, we observed no effect from both alde-
hydes if membranes were made from DOPC and CL (Fig. 1c).
3.2. Investigation of valinomycin–aldehyde interaction in planar bi-
layer membranes of different lipid compositions
To test whether the presence of PE is a common requirement
for aldehyde action on the transmembrane transport, we recon-
stituted lipid bilayer membranes with dodecadepsipeptide anti-
biotic valinomycin (0.05–0.1 mM) which is known to transport
potassium across a membrane. Fig. 1d (empty dots) demonstrates
that again, no increase in conductance was measured in the ab-
sence of PE. The relative membrane current increase, I/I0, in the
presence of PE was dependent on aldehyde concentration. The
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Fig. 1. Measurements of electrophysiological parameters of the bilayer membrane in the presence of different reactive aldehydes. (a) Schematic presentation of α,
β-unsaturated aldehydes used in the study. (b) Dependence of UCP-mediated membrane conductance, G, on RAs concentration. Lipid bilayer membranes were made from
E. coli lipids reconstituted with UCP1 and arachidonic acid (AA). The concentrations of lipid, UCP1 and AA were 1.5 mg/ml, 10 mg/(mg of lipid) and 15 mol% respectively. G0 is
conductance of FA activated UCP1 in the absence of RA. Insert. The effect of HHE (blue bars) and ONE (yellow bars) on the total membrane conductance G in the absence
(empty bars) and presence of UCP1 (dashed bars). Concentrations of HHE and ONE were 0.84 mM and 0.88 mM, respectively. (c) Inﬂuence of the membrane lipid com-
position on the activation of UCP1 in the presence of AA and RAs. Differently colored bars indicate FA activated UCP1 without RAs (white), in the presence of ONE (yellow)
and HNE (violet). Concentrations of lipid and UCP1 were 1.5 mg/ml and 5.3 mm/(mg lipid) respectively. Membrane lipid composition was DOPC:CL¼90:10 and DOPE:DOPC:
CL¼33:57:10 mol%. The buffer solution in all experiments contained 50 mM Na2SO4, 10 mM TRIS, 10 mM MES, 0.6 mM EGTA at pH 7.35 and T¼32 °C. (d) Dependence of
valinomycin-mediated membrane current, I, on RAs’ concentration in lipid bilayer membranes composed of different lipids. I(valinomycin) is a current measured in membranes
reconstituted only with valinomycin. Membranes were made from DOPE: DOPC (30:70 mol%, colored symbols) or from 100% DOPC (empty symbols). Valinomycin was added
to both compartments in a concentration of 0.05–0.1 mM. Buffer solution contained 50 mM KCl, 10 mM Tris, 10 mMMES, at pH 7.4 and T¼24 °C. Data points represent means
and standard deviation from 3–5 independent experiments. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
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was measured with UCP1: ONE4HNE»HHE (Fig. 1d, colored dots).
3.3. Modiﬁcations of DOPE head group by reactive aldehydes
Reactive aldehydes are known to form different adducts such as
the Michael adduct, Schiff base and pyrrole derivative with amino
acids [33] and aminophospholipids [13,34]. To reveal which ad-
ducts were formed by each aldehyde studied in our system, we
used high resolution mass spectrometry (MS) on ESI-Orbitrap.
Protonated ions of unmodiﬁed DOPE and DOPC were detected at
m/z 744.55 and 786.60, respectively (Fig. 2a). After incubation of
lipid vesicles with HNE, several new ions were observed at m/z
882.65, 900.67, 1020.76 and 1056.78 (Fig. 2b–d). Based on the high
accuracy of the Orbitrap mass analyzer, elemental compositions
for new compounds were assigned and structures of DOPE-HNE
adducts were proposed (Fig. 2e; Table S1). Proposed structures
were further conﬁrmed using consecutive tandem mass spectro-
metry experiments in a linear ion trap. CID MSn analysis allowed
identiﬁcation of single and double Schiff bases and Michaeladducts of HNE on a nucleophilic amino group of DOPE (Figs. S2–
S5). As illustrated in Fig. 2b, the most intensive product obtained
by co-incubation of lipid vesicles with HNE corresponded to the
Michael adduct at m/z 900.67. Intensities of Schiff base, double
Schiff base and double Michael adducts were at least one order of
magnitude lower than the intensity of the single Michael adduct
(however it was still possible to perform MS3 experiments illu-
strated in Supplementary Information). Indeed, it was shown by
numerous studies that Michael adducts formed by HNE with nu-
cleophilic substrates can undergo cyclization with formation of
hemiacetals (will have the same mass increment of 156 u) which
can be further dehydrated (mass increment of 138 u). Thus an
adduct at m/z 882.65 may in part correspond not only to the Schiff
base, but also to the dehydrated hemiacetal. Schiff base adducts
between HNE and primary amines are also known to undergo
cyclization with formation of a pentylpyrrole derivative accom-
panied by the loss of water. In the case of an HNE reaction with
DOPE, the product would have m/z value 864.6. However, the ion
at this m/z was not detected under conditions used in this ex-
periment. Furthermore, the formation of double and even triple
882.65
900.67
1020.76
1056.78
880.64
858.62
972.65
Fig. 2. ESI-Orbitrap MS spectra of RA-modiﬁed lipid vesicles. Lipid vesicles made of DOPE:DOPC:CL with a molar ratio of 45:45:10 mol% were incubated without aldehydes
(a), with HNE (b), ONE (c), and HHE (d). ■ indicate Schiff base adduct, ▲Michael adduct, □ double Schiff base adduct, and Δ double Michael adduct. (e) Covalent modiﬁcations
of PE by RAs. Proposed structures of HNE-, ONE- and HHE-modiﬁed DOPE based on mass spectrometry data.
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aldehydes was demonstrated previously in vitro [35].
Incubation of lipid vesicles with ONE resulted in the formation
of single Schiff bases which were detected at m/z 800.64 (Fig. 2c;
Fig. S6). Neither double Schiff bases nor double Michael adducts
were detected. HHE-DOPE co-incubation resulted in two new
compounds detected at m/z 858.62 and 972.65 (Fig. 2d) which
were assigned to single and double Michael adducts of HHE to theamino group of PE based on elemental composition (Table S1). The
structure of adducts was further conﬁrmed in MSn experiments
(Figs. S7 and S8). Previously, we reported the formation of dimeric
and even trimeric adducts of reactive aldehydes (alkenals) with
the nucleophilic head group of PE lipids [35]. We demonstrated
that after the ﬁrst Schiff base was formed, the addition of a second
molecule of aldehyde occurred via β-aldol condensation between
β-carbon (C2) atom of a ﬁrst aldehyde and the carbonyl group of a
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Fig. 3. Biophysical membrane parameters alteration by RAs. (a) Valinomycin- and
CCCP-mediated membrane current measured in the presence (Ix) and absence (I0)
of ONE (yellow, 0.34 mM), HNE (violet, 0.32 mM) and phloretin (red, 5 and 80 mM).
Membranes were made from DPhPC:DOPE (70:30 mol%). The buffer solution con-
tained 50 mM KCl, 10 mM TRIS, 10 mM MES at pH 7.4 at T¼25 °C. (b) Alteration of
membrane surface potential due to interaction of RAs with DOPE. Liposomes were
composed of DOPC: DOPE (50: 50, in mol%). Lipid concentration was 0.2 mg/ml.
Concentrations of HHE, HNE and ONE were 0.5 mM. The buffer solution contained
50 mM Na2SO4, 10 mM TRIS, 10 mM MES, 0.6 mM EGTA at pH 7.35 at T¼25 °C.
(c) Order parameter in DOPE:DOPC membrane bilayer in the presence of reactive
aldehydes and solvents. Liposomes contained DOPC:DOPE (50:50, in mol%). Con-
centration of liposomes was 5 mg/ml and of RAs was 0.5 mM. The concentration of
the spin label 5-doxyl stearic acid (5-DSA) was 7.5 nmol/(mg lipid). S0 was set to
100 and all other order parameters Sx were expressed in relation to this value. S0
and Sx were measured with or without solvents (Ethanol, methyl acetate). The
buffer solution and pH and T were as in B. Data points represent standard deviation
O. Jovanovic et al. / Free Radical Biology and Medicine 89 (2015) 1067–10761072second aldehyde molecule. Formation of hemiacetals between the
hydroxyl group in position C4 of the ﬁrst α,β-unsaturated alde-
hyde and a carbonyl group of a second aldehyde molecule were
proposed for double Michael adducts (Fig. 2e).
To conﬁrm that the RAs we used only interacted with an amine
group of DOPE, we performed GC–MS analysis of DOPE:DOPC:CL,
DOPC:CL and E. coli polar lipid samples in the presence of alde-
hydes (Fig. S9a, c and e) and in the presence of aldehydes and
arachidonic acid (Fig. S9b, d and f). In none of the cases was
modiﬁcation of PE-esteriﬁed fatty acids or AA acyl chains found.
3.4. Measurements of lipid membrane parameters in the presence of
aldehydes
To understand how aldehyde-PE adducts inﬂuence the activity of
membrane proteins/peptides, we compared different lipid mem-
brane parameters such as boundary potential, surface potential and
membrane order parameter in the presence of three aldehydes.
First, we measured the membrane conductance in the presence
of potassium ionophore valinomycin (0.05–0.1 mM) or proto-
nophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP, 1–
3 mM) to evaluate how the membrane energy barrier is altered by
RA-PE adducts. The results show that the barrier was decreased for
the positive charge and increased for the negative charge when
compared to the control without aldehydes (Fig. 3a). The effect of
ONE on valinomycin was more pronounced than that of HNE. The
decrease of the membrane energy barrier induced by aldehydes
coincides with changes induced by the well-known dipole modi-
ﬁer, phloretin, under the same conditions (Fig. 3a, red bars) [36].
Since phloretin and RH421 decreases and increases membrane
dipole potential, respectively, we added them to UCP-containing
membranes to test the idea that the dipole potential (DP) change
may be a mechanism responsible for the RA-mediated UCP acti-
vation. However, Fig. S10a–b shows that changes in conductance
of membranes reconstituted with UCP1 and FA in the presence of
two DP modiﬁers does not indicate the involvement of DP in the
alteration of protein activity. It means that even if aldehydes
change the dipole potential as a part of a boundary potential, it
does not seem to be the molecular mechanism that affects UCP1
transport. In contrast, phloretin decreased the conductance of
membranes reconstituted with arachidonic acid in a dose-depen-
dent manner, whereas RH 421 increased it (Fig. S10c–d).
To evaluate whether a RA-mediated decrease of boundary po-
tential may in part be explained by alteration of surface potential
as previously described for calcium channel blocker verapamil
[37], we compared the zeta-potential of liposomes composed of
DOPC and of DOPC:DOPE (50:50 mol%). We have omitted CL from
the lipid composition, because CL, as a strong anionic lipid, alters
the surface potential itself. Ethanol (EtOH) and methyl acetate
(MA) did not alter the zeta-potential. Our results show that RAs
signiﬁcantly increased negative membrane zeta-potential in the
following order HHEoHNE⪡ONE in DOPC:DOPE, but not in DOPC
lipid bilayers (Fig. 3b).
Finally, we evaluated the inﬂuence of RAs on the order para-
meter, S, using an electron paramagnetic resonance technique
(EPR) and 5-doxyl stearic acid. We compared the liposomes
without additives (negative control), with AA (positive control [5])
and with different RAs and solvents (ethanol, MA). We found that
only the incubation of liposomes with ONE lead to small but sig-
niﬁcant decreases in S for DOPC/DOPE liposomes (Fig. 3c; yellow
bar). Again, we did not reveal any changes due to RA action in
DOPC bilayers. These results indicate that modiﬁcation of PE by
ONE leads to the alteration in spatial arrangement of aliphatic
chains in bilayers, and thus to an increase in the bilayers' ﬂuidity.
The PE-adducts formed by HNE and HHE do not modify the
membrane order parameter.from at least 3 independent experiments.
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Fig. 4. Localization of (a) HNE-PE adducts and (b) ONE-Schiff adduct in DPPC bilayer (gray) revealed by molecular dynamics simulations (MD). Left column: selected MD
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position in lipid bilayer membranes as revealed by MD simulations.
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compositions
To understand how the RAs studied in the experimental part of
this work alter properties of the lipid bilayer membrane, we per-
formed MD simulations of DPPC bilayer with ONE, HNE, and RA-
DOPE adducts (Fig. 4 and Figs. S11 and S12). The evaluation of
number density proﬁles shows large qualitative differences be-
tween bilayers containing HNE adducts (both Michael and Schiff
base adducts, Fig. 4a), and those containing only ONE Schiff base
adducts (Fig. 4b). As indicated in Fig. 4b, the terminal carbon atom
in the aliphatic tail of the ONE-Schiff base adducts (orange) is
preferentially located close to the headgroup region with a density
maximum at a distance of approximately 0.5 nm from the phos-
phorus atom (black) of the DPPC, which denotes the water–lipid
interface. In contrast, the terminal carbon atoms of aliphatic tails
of HNE-Michael adducts (red, Fig. 4a) and HNE-Schiff base adducts
(yellow, Fig. 4a) are located deeper within the bilayer at a distance
of approximately 1 nm from the phosphorus atom (black). Inter-
estingly, the number density proﬁles of terminal carbon atoms for
both HNE adducts, Michael and Schiff base adducts, overlap each
other. It suggests great similarity between both adducts which
results in their comparable position in lipid bilayers. Evidently the
PE adducts which are formed by different RAs, diversely altered
the lipid density proﬁle in the bilayer as well: the ONE-Schiff base
adducts contributed to an increase in lipid density in the head-
group region, whereas the HNE adducts increased the lipid density
deeper into the region of aliphatic chains. The difference in the
behavior of HNE and ONE adducts lies in their capability to form
hydrogen bonds with DPPC phosphate and especially DPPC car-
bonyl groups which are located below the phosphate groups close
to the aliphatic chain region. In particular, hydrogen bonds are
readily formed between hydroxyl groups, present in HNE-Michael
and HNE-Schiff adducts, with DPPC carbonyl groups which as a
consequence results in the penetration of the adduct aliphatic tail
deeper into the bilayer. In contrast, the carbonyl group in the ONE-
Schiff adduct is not able to make hydrogen bonds with DPPC
carbonyl groups, which in turn shifts the aliphatic tail closer to the
water phase (Fig. 4c).
Analysis of the number density proﬁles shows that addition of
ONE to the DPPC bilayer results in their stabilization in the lipid
bilayer (Fig. S11), which is similar to what was previously de-
monstrated for HNE [38]. ONE increases the area per lipid by ap-
proximately 21%, similar to the effect of HNE on DPPC lipids (Fig.
S12). Formation of ONE-PE adducts increased the area per lipid by
only 8%, while formation of HNE-PE adducts increased the area per
lipid by only 12%. The difference in area per lipid between HNE
and ONE adducts is caused by the structural differences between
these adducts as suggested in Fig. 4c. Interestingly, MD simulation
did not show differences in area per lipid for HNE Michael adduct
and HNE Schiff base adduct which once again indicates their great
similarity in localization in lipid bilayer. Furthermore, the struc-
tural differences between HNE/ONE adducts and the different
position of oxygen (arrow in Fig. 4c) could be the reason for the
differences observed in surface potential measurements (Fig. 3b):
oxygen in ONE-adducts is generally localized at the water–lipid
region (Fig. 4b; right, red) in contrast to the oxygen in HHE- and
HNE-adducts (Fig. 4a; right, red and green), which are mostly di-
rected towards the membrane core.4. Discussion
Biological effects on proteins mediated by HNE and ONE are
usually attributed to their capacity to modify molecules by binding
covalently to the nucleophilic sites such as cysteine, lysine andhistidine (for review [6,33,39]). The ability of HNE to form Michael
adducts with phosphatidylethanolamine (PE) was ﬁrst suggested
by Guichardant et al. [13]. Few studies have reported that other
aldehydes also covalently bind to aminophospholipids, forming
Michael and Schiff base adducts [14,40,41]. However, the con-
sequences of such lipid modiﬁcation for the function of membrane
proteins and the type of adducts formed by different aldehydes
have not yet been investigated. We have now demonstrated that
the mechanism of aldehydes action on the transporter function is
based on the formation of PE-aldehyde adducts, which for their
part modify the biophysical properties of the membrane (Fig. 5).
The mass spectrometry analysis revealed that all three RAs we
examined, formed different adducts upon binding to the amino
group of PE. In contrast to the previous work, in which only two
HNE-derived adducts (Michael and Schiff base adducts) have been
described [13], we have now showed that PE-HNE interaction re-
sults in the formation of four adducts including double Michael
and Schiff base adducts. The amount of formed adducts obviously
depends on the PE species and hydrophobicity of aldehydes as
suggested in the study with isolated human blood platelets [14].
Notably, ONE, known as a most toxic aldehyde in cells [42], also
revealed the most pronounced effect on conductance of bilayer
membranes reconstituted with recombinant UCP1, valinomycin or
CCCP. Since ONE forms merely one adduct with PE, we concluded
that the formation of this ONE-Schiff base adduct may mainly be
responsible for the activity change of studied transporters. In
contrast, Michael, double Michael and Schiff base adducts formed
by HNE and Michael adducts derived from HHE only moderately
contributed to these changes. MD simulations reveal that struc-
turally distinct PE adducts inﬂuence bilayer membrane properties
in different ways. Thus, the increase of area per lipid is more
pronounced in bilayers that contain both HNE adducts than those
having only ONE Schiff base adduct. However, it seems to be more
important that aliphatic chains of ONE Schiff adducts are located
closer to the lipid headgroup region, in contrast to aliphatic chains
of both Michael and Schiff HNE adducts which penetrate deeper
into the bilayer interior. This fact suggests that the modiﬁcation of
the lipid headgroup position primarily led to the alteration of the
transport properties of studied proteins.
The experimental data revealed that RA-PE adducts affect to
different extent several membrane biophysical properties, such as
boundary potentials and membrane order parameters, which in
turn individually altered the function of each membrane trans-
porter. ONE and to a lesser extent HNE decreased the positive
membrane energy barrier that led to the increase of the potassium
transport rate mediated by valinomycin. However, it does not
seem to be the molecular mechanism which would explain the
aldehyde action on mitochondrial transporter UCP1, because no
effect on UCP1 function was observed in the presence of dipole
potential modiﬁers phloretin and RH 421 (Fig. S10). We suggest
that an increase in UCP1-mediated conductance rather depends on
membrane ﬂuidity and/or membrane surface potential, as pre-
viously shown for UCP2 in the presence of negatively charged
phosphoinositides [43]. These mechanisms would be conform
with the view that fatty acids, known as activators of UCP1
transport, bind to the protein on the protein–lipid surface as
suggested by the FA-cycling hypothesis and in the subsequent
works [44,45].
Based on the presented data we hypothesized that the shown
PE-mediated mechanism of RA action is not speciﬁc for UCP1, but
can be common for all membrane proteins. This hypothesis is al-
ready supported in the present work by data demonstrating that
the activity of a small membrane transporter valinomycin is af-
fected by PE-adducts through the boundary potential alteration. To
test this hypothesis further experiments with other membrane
proteins are required.
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Fig. 5. Mechanism of aldehyde action on transmembrane transporters in PE-free (left column) and PE-containing bilayers (right column). UCP-mediated proton translocation
in the presence of free fatty acids (FFAs) and valinomycin-mediated Kþ transport are faster in bilayers containing RA-PE adducts (b, d) than in PC bilayers, containing ONE (a,
c).
O. Jovanovic et al. / Free Radical Biology and Medicine 89 (2015) 1067–1076 10755. Conclusion
Our results show that at least two molecular mechanisms can
explain the action of aldehydes on proteins or peptides at cellular
level. On the one side, RAs may directly modify protein con-
formation or function by binding to several positively charged
amino acids. On the other side, aldehydes form different adducts
with PE which led to the alteration of membrane properties and
ﬁnally to the modiﬁcation of protein function. Whereas the ﬁrst
mechanism may be more relevant for hydrophilic proteins, the
second mechanism seems to be crucial for membrane proteins.
Membrane lipid asymmetry and PE abundance in the membrane
may thereby play a regulatory role. The aldehyde´s ability to affect
the molecules by different mechanisms would explain the di-
versity of aldehyde effects observed in cells and their involvement
in the onset and progression of many diseases.Notes
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